Sandra Brunner, PhD, is a commercial leader in biopharma with a strong belief in the power of teams and the necessity for constant change. They earned a PhD in human molecular genetics and neuroscience from the University of Zurich and have held various roles in the biopharmaceutical industry, including positions at Amgen and Bristol-Myers Squibb. Their experience includes strategic marketing and leadership in oncology, rare diseases, and metabolic health. Currently, they serve on the board of the shqa swiss health quality association, contributing to health quality initiatives.
This person is not in the org chart
This person is not in any teams
This person is not in any offices